Implementing an extroversial strategic plan, we opened our horizons beyond national borders with the objective to become an important player in the global pharmaceutical arena. Our business in the USA are comprised of two distinct areas: drug deilivery and drug formulation. Our  research and development activity takes place in East Windsor, New Jersey, nearby Princeton University, the "heart" of pharmaceutical industry. Our proprietary facilities of 110 sm house state-of-the-art research laboratories, a pilot plant approved by FDA for the production and packaging of clinical samples according to International Good Manufacturing Practices, as well as corporate offices.
In France we are active in the Supercritical Fluid Technology through our subsidiary Hitex in Vannes. At our premises we are active in the production of extracts without the use of solvents, for 3rd party. The most well-known are Lipowheat and Miliaskin. Both are derived using Supercritical Fluid Technology and are used in cosmetics and food supplement products. Lipowheat is extracted from wheat while Miliaskin is derived from millet (a type of grain).